-+ 0.00%
-+ 0.00%
-+ 0.00%

Shares of the South Korean biopharmaceutical company Celltrion rose 10% to 199,100 won. The company and Eli Lilly reached a $473 million contract manufacturing agreement.

智通財經·01/02/2026 01:49:03
語音播報
Shares of the South Korean biopharmaceutical company Celltrion rose 10% to 199,100 won. The company and Eli Lilly reached a $473 million contract manufacturing agreement.